Literature DB >> 19540606

Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease.

Cesare de Gregorio, Gaetano Morabito, Marco Cerrito, Giuseppe Dattilo, Giuseppe Oreto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540606     DOI: 10.1016/j.ijcard.2009.05.060

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  12 in total

Review 1.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

Review 2.  QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes.

Authors:  Katharina Wenzel-Seifert; Markus Wittmann; Ekkehard Haen
Journal:  Dtsch Arztebl Int       Date:  2011-10-14       Impact factor: 5.594

3.  Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports.

Authors:  Christopher Kogut; Ericka Breden Crouse; W Victor R Vieweg; Mehrul Hasnain; Adrian Baranchuk; Geneviève C Digby; Jayanthi N Koneru; Antony Fernandez; Anand Deshmukh; Jules C Hancox; Ananda K Pandurangi
Journal:  Ther Adv Drug Saf       Date:  2013-10

4.  Evaluation of a QT nomogram for risk assessment after antidepressant overdose.

Authors:  W Stephen Waring; Ann Graham; Julie Gray; Allen D Wilson; Catherine Howell; D Nicholas Bateman
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

5.  Drug-specific risk of severe QT prolongation following acute drug overdose.

Authors:  Sharan L Campleman; Jeffery Brent; Anthony F Pizon; Joshua Shulman; Paul Wax; Alex F Manini
Journal:  Clin Toxicol (Phila)       Date:  2020-04-07       Impact factor: 4.467

Review 6.  Citalopram and cardiac toxicity.

Authors:  M J Cooke; W S Waring
Journal:  Eur J Clin Pharmacol       Date:  2012-09-21       Impact factor: 2.953

Review 7.  FDA drug safety communications: a narrative review and clinical considerations for older adults.

Authors:  Zachary A Marcum; Joseph P Vande Griend; Sunny A Linnebur
Journal:  Am J Geriatr Pharmacother       Date:  2012-06-08

8.  Prolonged QTc interval and torsades de pointes induced by citalopram.

Authors:  Anand Deshmukh; Kyle Ulveling; Venkata Alla; Hussam Abuissa; Kelly Airey
Journal:  Tex Heart Inst J       Date:  2012

Review 9.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

10.  Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study.

Authors:  Elena Qirjazi; Eric McArthur; Danielle M Nash; Stephanie N Dixon; Matthew A Weir; Akshya Vasudev; Racquel Jandoc; Lorne J Gula; Matthew J Oliver; Ron Wald; Amit X Garg
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.